July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The anti-inflammatory effect of substance P on diabetic complication with diabetic rat model
Author Affiliations & Notes
  • Sung Rae Noh
    Ophthalmology, Kyung Hee University Medical Center, Seoul, Korea (the Republic of)
  • Jae Min Kim
    Ophthalmology, Kyung Hee University Medical Center, Seoul, Korea (the Republic of)
  • Kiyoung Kim
    Ophthalmology, Kyung Hee University Medical Center, Seoul, Korea (the Republic of)
  • Eung-Suk Kim
    Ophthalmology, Kyung Hee University Medical Center, Seoul, Korea (the Republic of)
  • Hyun Sook Hong
    Regenerative medicine, Kyunghee university medical center, Seoul, Korea (the Republic of)
  • Seung-Young Yu
    Ophthalmology, Kyung Hee University Medical Center, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Sung Rae Noh, None; Jae Min Kim, None; Kiyoung Kim, None; Eung-Suk Kim, None; Hyun Sook Hong, None; Seung-Young Yu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3590. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sung Rae Noh, Jae Min Kim, Kiyoung Kim, Eung-Suk Kim, Hyun Sook Hong, Seung-Young Yu; The anti-inflammatory effect of substance P on diabetic complication with diabetic rat model. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3590.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate anti-inflammatory effect in Type 2 diabetic rats (OLETF) after intravenous Substance P (SP) injection

Methods : Retinal nerve fiber layer (RNFL) thicknesses were measured manually at 1300 μm from the center of the optic nerve head using SD-OCT. 5nmole/kg Substance P was injected intravenously twice a week from 27 to 30 weeks. Serum inflammatory cytokines, serum liver enzyme concentration, spleen and bone marrow changes were analyzed histologically and immunologically.

Results : At 28 weeks, RNFL thickness was significantly lower in OLETF than control group. From 29 weeks (2 weeks after injection) RNFL thickness showed significant increase in SP injection group maintained by 31 weeks. In histologic analysis, SP injection group presented decrease of GFAP staining, cell apoptosis, serum liver enzymes and inflammatory cytokines. In the spleen, SP injection group presented decrease of white pulp zone(lymphocyte zone)/total area ratio. In the bone marrow, bone marrow colony forming efficiency was higher than control group. Suppression of fatty marrow progression was observed.

Conclusions : Substance P injection showed anti-inflammatory effect in retinal neurodegeneration as early change of diabetic retinopathy and in immune reaction of spleen. In bone marrow, SP enhanced activation of mesenchymal stem cells-mediated immune modulation. Therefore, SP might prevent retinal neurodegeneration through systemic anti-inflammatory reaction and stimulation and mobilization of bone marrow cell.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×